Should Your Portfolio Include PINS Stock Post Modest Q2 Results? — Neutral
PINS Zacks Investment Research — August 13, 2025Pinterest's solid Q2 revenues and AI-driven ad tools fuel growth, but rising costs and tough competition weigh on margins.
TSM's Nanosheet Roadmap Advances: Can it Maintain Tech Leadership? — Positive
TSM Zacks Investment Research — August 13, 2025Taiwan Semiconductor pushes nanosheet tech with N2, N2P, A16, and A14 nodes, targeting speed, power, and density gains to extend chip leadership.
Market rally is in an unstoppable 'sugar high,' analyst says, plus CoreWeave tumbles after earnings — Neutral
CRWV Yahoo Finance — August 13, 2025Opening Bid anchor Brian Sozzi breaks down the latest market news for August 13, 2025. F/m Investments CEI & CIO Alex Morris joins our panel to explain why he believes the market rally will continue, his strategy for investing, Fed rate cuts, and inflation.
QuantumScape: Adding To My Position In The Current Dip — Positive
QS Seeking Alpha — August 13, 2025QuantumScape remains a speculative play, but its advancements on milestones and robust cash reserves support my continued buy rating. Successful integration of next-gen Cobra separator boosts production efficiency, positioning QS for future solid-state battery demand and OEM interest. Strong financials, asset-light model, and Volkswagen partnership ensure sustainability, with a cash runway of up to 32 months including new funding.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The J.M. Smucker Company - SJM — Neutral
SJM GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The J.M. Smucker Company (“Smucker” or the “Company”) (NYSE: SJM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript — Neutral
DMAC Seeking Alpha — August 13, 2025DiaMedica Therapeutics Inc. (NASDAQ:DMAC ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Dietrich John Pauls - President, CEO & Director Julie Krop - Chief Medical Officer Scott Kellen - CFO & Corporate Secretary Conference Call Participants Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Operator Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q2 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the …
MercadoLibre Faces Ongoing Margin Strain: Is Profit Growth Slowing? — Positive
MELI Zacks Investment Research — August 13, 2025Heavy spending on payments, shipping and credit expansion is fueling MELI's market reach, yet margins reflect the strain of rapid growth plans.
Dave Stock Skyrockets 416% in a Year: Should You Play or Let Go? — Positive
DAVE Zacks Investment Research — August 13, 2025DAVE's expanding user base fuels revenue gains, but credit risks and competition threaten its growth path.
Radian Outperforms Industry, Trades at Discount: How to Play the Stock — Positive
RDN Zacks Investment Research — August 13, 2025RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
SolarEdge Technologies Q2 Earnings Beat, Revenues Increase Y/Y — Positive
SEDG Zacks Investment Research — August 13, 2025SEDG posts a narrower Q2 loss as revenues climb 9.1% year over year, driving shares up 2.8%.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC — Neutral
EHC GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Lucid Group, Inc. posted strong delivery growth and revenue expansion in Q2 '25, but missed earnings estimates and continues to suffer from unsustainable negative gross margins. Despite lowering FY 2025 delivery guidance, Lucid still projects up to 95% year-over-year delivery growth, driven by the Gravity SUV. Lucid has a healthy liquidity profile and access to billions in cash to finance the ramp of its production plans.
Hydro One Ltd (HRNNF) Q2 2025 Earnings Call Transcript — Neutral
H HRNNF Seeking Alpha — August 13, 2025Hydro One Ltd (OTCPK:HRNNF) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants David Lebeter - President, CEO & Director Henry P. Taylor - Executive VP, Chief Financial & Regulatory Officer Wassem Khalil - Director of Investor Relations Conference Call Participants Benjamin Pham - BMO Capital Markets Equity Research John Mould - TD Cowen, Research Division Mark Thomas Jarvi - CIBC Capital Markets, Research Division Maurice Choy - RBC Capital Markets, Research Division Patrick Kenny - National Bank Financial, Inc., Research Division Robert Hope - Scotiabank Global Banking and Markets, Research Division Operator Good morning, ladies and …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK — Neutral
GSK GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
S&P 500 ETFs Hit Record Highs as Index Tops 6,400: What's Next? — Positive
IVV SPY VOO Zacks Investment Research — August 13, 2025ETFs like VOO, SPY and IVV hit record highs as the S&P 500 tops 6,400, fueled by AI-led tech gains and rising hopes for Fed rate cuts.
Here's What Key Metrics Tell Us About Loar Holdings Inc. (LOAR) Q2 Earnings — Positive
LOAR Zacks Investment Research — August 13, 2025Although the revenue and EPS for Loar Holdings Inc. (LOAR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZEEKR Intelligent Technology Holding Limited - ZK — Neutral
ZK GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ZEEKR Intelligent Technology Holding Limited (“Zeekr” or the “Company”) (NYSE: ZK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
BigBear.ai Holdings: More Pain Coming For Dip Buyers (Downgrade) — Neutral
BBAI Seeking Alpha — August 13, 2025It's time to downgrade BigBear.ai Holdings, Inc. to Sell again. A less confident outlook with withdrawn profitability guidance could throttle buying sentiments. While BigBear.ai is slated to capture legislative tailwinds from the OBBBA, execution risks could impede its ability to monetize such gains. Current valuation is well-stretched, and BBAI is not expected to be profitable in the near term.
Subodh Kulkarni, Rigetti Computing president and CEO, joins CNBC's 'Squawk on the Street' to discuss outlooks on Rigetti's quantum capabilities, what technical hurdles remain, and much more.
Etoiles Capital Group Co., Ltd Announces Closing of Underwriters' Over-Allotment Option in Connection with Initial Public Offering — Neutral
EFTY GlobeNewsWire — August 13, 2025HONG KONG, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Etoiles Capital Group Co., Ltd (Nasdaq: EFTY), a Hong Kong-based financial services provider, today announced that it closed the sale of an additional 210,000 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriters' over-allotment option granted in connection with the Company's initial public offering (“IPO”, together with such over-allotment closing, the “Offering”), at the IPO price of $4.00 per share, less underwriting discounts. As a result, the Company has raised aggregate gross proceeds of $6,440,000, including the previously announced IPO gross proceeds of $5,600,000, prior to …